
Actide 0.05mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Actide 0.05mg Injection
Octreotide 0.05mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, also preventing post-pancreatic surgery complications. Administration is solely by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician. Consistent use maximizes therapeutic effect; discontinue only upon medical advice. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Uses of Actide 0.05mg Injection
Overgrowth of tissues due to excess growth hormone|Neuroendocrine tumors secreting hormones|Life-threatening esophageal vein rupture
Major Benefits of Actide 0.05mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Actide 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Actide 0.05mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Actide 0.05mg Injection works:
Actide 0.05mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication reduces the activity of several hormones, including growth hormone, and diminishes esophageal bleeding by vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Actide 0.05mg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable form of Actide at a 0.05mg dose is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Actide 0.05mg Injection while breastfeeding appears unlikely to pose a substantial threat to the infant. Available human data indicates minimal risk to the nursing child.
DrivingSAFE
Driving ability is typically unaffected by Actide 0.05mg Injection.
KidneySAFE IF PRESCRIBED
Actide 0.05mg Injection presents no safety concerns for patients with impaired renal function; dosage modification is unnecessary.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Actide 0.05mg Injection; dosage modification may be necessary. Medical advice is recommended.
What if you forget to take Actide 0.05mg Injection :
Should you forget a dose of Actide 0.05mg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Actide 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Category | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Somatostatin analogs |
